XML 51 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2010
Dec. 31, 2018
Dec. 31, 2017
Fair Value Measurement [Line Items]      
Cumulative Liability   $ 18,400 $ 17,500
Manhattan and Ariston Pharmaceuticals Merger [Member]      
Fair Value Measurement [Line Items]      
Notes Issued $ 15,500    
Debt Instrument, Convertible, Conversion Price $ 1,125    
Percentage Of Cash Proceeds From Operation To Repay Convertible Debt 50.00%    
Debt Instrument, Term 5 years    
Debt Instrument, Interest Rate During Period 5.00%    
Convertible Notes Payable [Member]      
Fair Value Measurement [Line Items]      
Cumulative Liability     $ 17,500
Debt Instrument, Convertible, Conversion Price   $ 1,125 $ 1,125
Debt Instrument, Interest Rate During Period     5.00%